Aigen Investment Management, LP Xeris Biopharma Holdings, Inc. Transaction History
Aigen Investment Management, LP
- $579 Million
- Q1 2025
A detailed history of Aigen Investment Management, LP transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Aigen Investment Management, LP holds 16,769 shares of XERS stock, worth $163,665. This represents 0.02% of its overall portfolio holdings.
Number of Shares
16,769Holding current value
$163,665% of portfolio
0.02%Shares
4 transactions
Others Institutions Holding XERS
# of Institutions
215Shares Held
89.8MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$101 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$95.8 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$37.4 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$36.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$35.6 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1.33B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...